A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
Clinical trial NCT02505334 · COMPLETED
Trial details
- NCT number
- NCT02505334
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-21
- Primary completion
- 2017-05-02
- Enrollment
- 635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.